Literature DB >> 19955922

B7-H4 expression promotes tumorigenesis in ovarian cancer.

Lei Cheng1, Jie Jiang, Ran Gao, Shuangyan Wei, Fangfang Nan, Shaoru Li, Beihua Kong.   

Abstract

INTRODUCTION: It has been previously shown that B7-H4, one of the B7 family members that serve as negative regulators of T cell function, has altered expression levels in a variety of cancers, overexpression of B7-H4 promotes cellular transformation. However, there is still lack of adequate evidence to establish a direct connection between B7-H4 expression and malignant transformation.
METHODS: Herein, we constructed pE-green fluorescent protein-N1/B7-H4 mammalian expression vector and transfected into B7-H4-negative human ovarian cancer cell line SKOV3. Cellular proliferation, apoptosis, adhesion, motility, and invasion were examined in vitro. Cells injected subcutaneously into severe combined immunodeficient mouse were analyzed for the possible functions of B7-H4 in ovarian tumorigenesis in vivo.
RESULTS: Fluorescence microscopy studies confirmed that the B7-H4-green fluorescent protein localizes in the cytoplasm of SKOV3/B7-H4 cells, whereas green fluorescent protein is uniformly distributed throughout the cell. B7-H4 promoted cellular proliferation rate and increased cell adhesion, migration, and invasion. In addition, SKOV3 cells expressing B7-H4 gained growth advantage in the xenograft model in vivo.
CONCLUSIONS: These studies demonstrate that B7-H4 directly promotes malignant transformation of ovarian cancer cell line, and provides a potential therapeutic strategy for targeting B7-H4 to inhibit progression of human ovarian cancers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955922     DOI: 10.1111/IGC.0b013e3181ad0fa2

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  27 in total

1.  Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy.

Authors:  Jenessa B Smith; Evripidis Lanitis; Denarda Dangaj; Elizabeth Buza; Mathilde Poussin; Caitlin Stashwick; Nathalie Scholler; Daniel J Powell
Journal:  Mol Ther       Date:  2016-07-21       Impact factor: 11.454

2.  B7-H4 downregulation induces mitochondrial dysfunction and enhances doxorubicin sensitivity via the cAMP/CREB/PGC1-α signaling pathway in HeLa cells.

Authors:  Hyoung Kyu Kim; In-Sung Song; Sun Young Lee; Seung Hun Jeong; Sung Ryul Lee; Hye Jin Heo; Vu Thi Thu; Nari Kim; Kyung Soo Ko; Byoung Doo Rhee; Dae Hun Jeong; Young Nam Kim; Jin Han
Journal:  Pflugers Arch       Date:  2014-12       Impact factor: 3.657

Review 3.  B7-H4 as a potential target for immunotherapy for gynecologic cancers: a closer look.

Authors:  Jenessa B Smith; Caitlin Stashwick; Daniel J Powell
Journal:  Gynecol Oncol       Date:  2014-03-20       Impact factor: 5.482

Review 4.  Tumor infiltrating lymphocytes in ovarian cancer.

Authors:  Phillip P Santoiemma; Daniel J Powell
Journal:  Cancer Biol Ther       Date:  2015-04-20       Impact factor: 4.742

5.  B7-H4 expression in various tumors determined using a novel developed monoclonal antibody.

Authors:  Yun Qian; Ling Shen; Linfang Cheng; Zhigang Wu; Hangping Yao
Journal:  Clin Exp Med       Date:  2010-12-29       Impact factor: 3.984

Review 6.  Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.

Authors:  Frank A Schildberg; Sarah R Klein; Gordon J Freeman; Arlene H Sharpe
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

7.  Expression of immune checkpoint molecules in endometrial carcinoma.

Authors:  Jia Liu; Yuling Liu; Wuliang Wang; Chenyang Wang; Yanhong Che
Journal:  Exp Ther Med       Date:  2015-08-28       Impact factor: 2.447

8.  Blocking the B7-H4 pathway with novel recombinant antibodies enhances T cell-mediated antitumor responses.

Authors:  Denarda Dangaj; Nathalie Scholler
Journal:  Oncoimmunology       Date:  2013-07-31       Impact factor: 8.110

9.  B7-H4 overexpression correlates with a poor prognosis for cervical cancer patients.

Authors:  Wenting Liu; Kiyosumi Shibata; Yoshihiro Koya; Hiroaki Kajiyama; Takeshi Senga; Mamoru Yamashita; Fumitaka Kikkawa
Journal:  Mol Clin Oncol       Date:  2013-12-12

Review 10.  B7 family checkpoint regulators in immune regulation and disease.

Authors:  Sabrina Ceeraz; Elizabeth C Nowak; Randolph J Noelle
Journal:  Trends Immunol       Date:  2013-08-13       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.